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Cui, Jian, Rong Zhang, Thad E. Wilson, Sarah Witkowski, Craig G. Crandall, and Benjamin D. Levine.
Nitric oxide synthase inhibition does not affect regulation of
muscle sympathetic nerve activity during head-up tilt. Am J
Physiol Heart Circ Physiol 285: H2105–H2110, 2003. First
published July 3, 2003; 10.1152/ajpheart.01076.2002.—To
test the hypothesis that systemic inhibition of nitric oxide
(NO) synthase does not alter the regulation of sympathetic
outflow during head-up tilt in humans, in eight healthy
subjects NO synthase was blocked by intravenous infusion of
NG-monomethyl-L-arginine (L-NMMA). Blood pressure, heart
rate, cardiac output, total peripheral resistance (TPR), and
muscle sympathetic nerve activity (MSNA) were recorded in
the supine position and during 60° head-up tilt. In the supine
position, infusion of L-NMMA increased blood pressure, via
increased TPR, and inhibited MSNA. However, the increase
in MSNA evoked by head-up tilt during L-NMMA infusion
(change in burst rate: 24 ⫾ 4 bursts/min; change in total
activity: 209 ⫾ 36 U/min) was similar to that during head-up
tilt without L-NMMA (change in burst rate: 23 ⫾ 4 bursts/
min; change in total activity: 251 ⫾ 52 U/min, n ⫽ 6, all P ⬎
0.05). Moreover, changes in TPR and heart rate during
head-up tilt were virtually identical between the two conditions. These results suggest that systemic inhibition of NO
synthase with L-NMMA does not affect the regulation of
sympathetic outflow and vascular resistance during head-up
tilt in humans.
baroreceptors; nervous system; autonomic; orthostatic; microneurography

(NO) is synthesized in both the vascular
endothelium and neurons of the central nervous system from the guanidino nitrogen of L-arginine via NO
synthase (10, 24). NO plays a critical role in the control
of blood flow in the peripheral circulation (1, 24, 27,
31). However, the role of NO in central control of the
cardiovascular system remains controversial. For example, microinjections of NG-monomethyl-L-arginine
(L-NMMA), a competitive inhibitor of NO synthase
(25), directly into the nucleus tractus solitarius of rabbits (13) or rats (32) or the rostral ventrolateral medulla of rats (32, 35) increased arterial blood pressure
and renal sympathetic nerve activity. These findings
suggest a role of NO in central control of the cardioNITRIC OXIDE
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vascular system. However, the gain of the baroreflex is
not altered by either central or systemic infusions of
L-NMMA in rabbits (13, 17, 21, 22).
Similar to these animal studies, systemic infusion of
L-NMMA increased muscle sympathetic outflow in supine humans (18, 23, 28) but did not change baroreflex
function as detected by the cross-spectral or sequence
methods (3). Moreover, baroreflex regulation of muscle
sympathetic nerve activity (MSNA) during low levels of
lower body negative pressure (LBNP; i.e., ⫺30 mmHg)
was not altered after inhibition of NO synthase in
healthy humans (30). However, in those studies, the
assessment of baroreflex function was limited to relatively small changes in baroreceptor perturbations
caused by spontaneous changes in blood pressure or
low levels of LBNP. Moreover, in most of the cited
studies, comprehensive hemodynamic assessments of
cardiac output, stroke volume, and total peripheral
resistance (TPR) were not performed. Thus the contribution of NO in modulating baroreflex control of blood
pressure during more pronounced baroreceptor unloading has not been studied thoroughly.
In contrast to low levels of LBNP, the upright posture in humans causes more pronounced hydrostatic
fluid shifts, resulting in a greater pooling of blood
below the heart, and marked increases in MSNA, primarily through baroreceptor unloading. Moreover,
head-up tilt is used widely as a clinical test as well as
a research tool to assess autonomic function. Such a
perturbation may be more directly relevant in identifying a role for NO in circulatory control during baroreceptor unloading. On the basis of previous animal and
limited human studies, we hypothesized that inhibition of NO synthase with systemic infusion of L-NMMA
would not alter the regulation of sympathetic outflow
during head-up tilt. To test this hypothesis, we compared MSNA and hemodynamic responses during passive head-up tilt with and without systemic infusion of
L-NMMA in healthy individuals.
METHODS

Subjects. Eight subjects (6 men and 2 women) participated
in this study. The average age was 31 ⫾ 3 (mean ⫾ SE) yr,
The costs of publication of this article were defrayed in part by the
payment of page charges. The article must therefore be hereby
marked ‘‘advertisement’’ in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
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and all were of normal height (173 ⫾ 4 cm) and weight (73 ⫾
4 kg). All subjects were normotensive (supine blood pressures ⬍ 140/90 mmHg), were not taking medications, and
had no cardiovascular diseases. Subjects refrained from caffeine, alcohol, and heavy exercise 24 h before the study. This
study was approved by the Institutional Review Boards of
the University of Texas Southwestern Medical Center and
Presbyterian Hospital of Dallas. A written informed consent
from each subject was obtained before participation in this
study.
Measurements. Multifiber recordings of MSNA were obtained with a tungsten microelectrode inserted in the peroneal nerve. A reference electrode was placed subcutaneously
2–3 cm from the recording electrode. The recording electrode
was adjusted until a site was found in which muscle sympathetic bursts were clearly identified using previously established criteria (34). The nerve signal was amplified (50,000–
90,000 times), filtered with a bandwidth of 700–2,000 Hz,
and integrated with a time constant of 0.1 s (Iowa Bioengineering; Iowa City, IA). Mean voltage neurograms were displayed on a chart recorder. The nerve signal was also routed
to an oscilloscope and a loudspeaker for monitoring throughout the study.
Heart rate was obtained from the electrocardiogram interfaced with a cardiotachometer (1,000 Hz sampling rate,
CWE; Ardmore, PA). Intermittent blood pressure was measured from an upper arm by electrosphygmomanometry
(Suntech; Raleigh, NC), which remained at heart level during
tilt. Arterial blood pressure was also monitored with a Finapres device (Finapres, Ohmeda; Louisville, CO). We positioned the Finapres transducer at heart level to avoid spurious recordings due to changes of hydrostatic pressure gradients during changes in posture. Respiratory frequency was
monitored using piezoelectric pneumography (Pneumotrace;
Morro Bay, CA). Cardiac output was measured via a modified
rebreathing technique using acetylene as the soluble gas and
helium as the insoluble gas. Adequate mixing of the rebreathing gas in the lung was confirmed from the helium
measurement as previously described (19, 36). Blood pressure was measured during each cardiac output measurement. During both control and L-NMMA infusion conditions,
MSNA and hemodynamic measurements were obtained in
the supine position and during head-up tilt.
Protocol. All subjects were studied in a quiet, temperaturecontrolled (25°C) laboratory in the morning, at least 2 h
postprandial. After instrumentation, subjects rested quietly
in the supine position for at least 30 min. A hemodynamic
“steady state” was considered established when successive
measures of cardiac output were within 500 ml. Six minutes
of baseline data were obtained while the subject remained in
the supine position. Three blood pressure measures were
obtained during this period, followed by a cardiac output
measurement. Subjects were then tilted passively to the 60°
head-up position. After a 2-min stabilization period, 6 min of
data were obtained, again followed by a cardiac output measurement. The subjects were then returned to the supine
position, followed by 45 min of recovery. During this time, all
hemodynamic parameters had returned to pretilt baseline.
The NO synthase inhibitor L-NMMA (Clinalfa; Läufelfingen,
Switzerland) was then administered intravenously in the
following manner: a loading dose of 5 mg/kg over 15 min,
followed by a maintenance dose of 50 g 䡠 kg⫺1 䡠 min⫺1
throughout the remainder of the study. Previously, Mayer et
al. (20) showed stable blood concentrations of L-NMMA using
a similar regimen in humans. Thirty minutes after the onset
of the L-NMMA infusion, 6-min data collection ensued with
the subject remaining in the supine position. This period of
AJP-Heart Circ Physiol • VOL

data collection was followed by a repeat of the aforementioned head-up tilt procedure.
Data analysis. Data were sampled at 200 Hz via a dataacquisition system (Biopac System; Santa Barbara, CA) and
analyzed using LabView software (National Instruments;
Austin, TX). MSNA bursts were first identified in real time
by visual inspection of chart recorder data, coupled with the
burst sound from the audio amplifier. These bursts were
further evaluated via a computer software program that
identified bursts based on fixed criteria, including appropriate latency after the R wave of the electrocardiogram and a
signal-to-noise ratio of ⬎3:1 (7, 8). MSNA bursts were
counted during the 6-min data segments in the supine and
head-up tilt positions with and without L-NMMA. Burst rate
was calculated as both burst number per minute and burst
number per 100 heart beats. Total activity of MSNA was
defined as the burst area of the rectified and integrated
neurogram and expressed in arbitrary units by assigning the
mean burst area per minute during the 6-min supine baseline in the control condition a value of 100. Blood pressures
obtained in each condition (i.e., supine or head-up tilt) were
averaged for that condition. Mean arterial pressure (MAP)
was calculated as diastolic pressure plus one-third pulse
pressure measured from an upper arm. Mean heart rate was
averaged over the 6-min period of data collection. TPR was
calculated from the ratio of MAP and cardiac output.
Statistical analyses were performed using SigmaStat software (SPSS Science; Chicago, IL). The effects of L-NMMA
infusion on hemodynamic parameters in the supine position
were examined with a paired t-test. Hemodynamic responses
during tilt were evaluated with a two (condition: control vs.
L-NMMA) by two (position: supine vs. tilt) repeated-measures factorial ANOVA. Changes in MSNA, heart rate, MAP,
and TPR between supine and head-up tilt positions were
compared between infusion protocols (i.e., control or
L-NMMA) with a paired t-test. All values are reported as
means ⫾ SE. P values ⬍0.05 were considered statistically
significant.
RESULTS

Infusion of L-NMMA significantly increased TPR and
systolic and diastolic blood pressures but did not
change heart rate or cardiac output (Table 1). MSNA
was successfully recorded in six subjects. Representative recordings of integrated MSNA, arterial blood
pressure, and heart rate are shown in Fig. 1. Supine
MSNA, expressed as both burst rate and total activity,
decreased significantly during systemic infusion of LNMMA (n ⫽ 6; Fig. 2).
Head-up tilt during both control and L-NMMA conditions evoked significant increases in MSNA, TPR,
heart rate, and MAP, whereas stroke volume and pulse
pressure decreased significantly (Table 1 and Fig. 2).
MSNA, whether expressed as burst rate or total activity, was significantly lower during the L-NMMA trial
compared with the control trial regardless of the position. However, the increase in MSNA during head-up
tilt with L-NMMA (change in burst rate: 24 ⫾ 4 bursts/
min; change in total activity: 209 ⫾ 36 U/min) was not
significantly different from that during head-up tilt
without L-NMMA (change in burst rate: 23 ⫾ 4 bursts/
min, P ⫽ 0.708; change in total activity: 251 ⫾ 52
U/min, P ⫽ 0.560, n ⫽ 6). Moreover, the increase in
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Table 1. Mean values of hemodynamic parameters during control and L-NMMA infusion conditions
Control

SBP, mmHg
DBP, mmHg
MAP, mmHg
PP, mmHg
Heart rate, beats/min
CO, l/min
SV, ml
TPR, dyn 䡠 s 䡠 cm⫺5

L-NMMA

Supine

Tilt

Supine

Tilt

112.1 ⫾ 4.0
67.9 ⫾ 2.5
82.5 ⫾ 2.8
44.3 ⫾ 3.0
60.4 ⫾ 4.2
7.27 ⫾ 0.52
120 ⫾ 11
916 ⫾ 43

119.1 ⫾ 4.5*
82.4 ⫾ 3.0*
94.6 ⫾ 3.2*
36.8 ⫾ 3.2*
89.2 ⫾ 4.0*
6.05 ⫾ 0.33*
68 ⫾ 5*
1,273 ⫾ 62*

121.6 ⫾ 4.5†
79.5 ⫾ 2.8†
93.5 ⫾ 2.8†
42.1 ⫾ 1.8
57.5 ⫾ 4.8
7.34 ⫾ 0.60
125 ⫾ 12
1,052 ⫾ 68†

125.0 ⫾ 4.0*†
91.3 ⫾ 2.9*†
102.4 ⫾ 3.1*†
33.8 ⫾ 2.3*
84.1 ⫾ 3.9*
6.37 ⫾ 0.45
76 ⫾ 7*
1,325 ⫾ 77*

Values are means ⫾ SE; n ⫽ 8 subjects. Blood pressure was measured from a upper arm by electrosphygmomanometry. L-NMMA, N Gmonomethyl-L-arginine; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; CO,
cardiac output; SV, stroke volume; TPR, total peripheral vascular resistance. * P ⬍ 0.05 compared with supine under the same drug condition;
† P ⬍ 0.05 compared with control with the same body position.

heart rate during head-up tilt with L-NMMA (change
in heart rate: 25.1 ⫾ 2.7 beats/min) was not significantly different from the control condition (change in
heart rate: 27.3 ⫾ 3.0 beats/min, P ⫽ 0.253, n ⫽ 8). The
decrease in stroke volume during head-up tilt with
L-NMMA (change in stroke volume: ⫺48.9 ⫾ 5.5 ml/
beat) was similar to that in the control condition
(change in stroke volume: ⫺51.6 ⫾ 6.3 ml/beat, P ⫽
0.637, n ⫽ 8). Finally, the change in TPR (273 ⫾ 79
dyn 䡠 s 䡠 cm⫺5) and change in MAP (8.9 ⫾ 2.2 mmHg)
during head-up tilt with L-NMMA were not significantly different from the control trial (change in TPR:
357 ⫾ 55 dyn 䡠 s 䡠 cm⫺5, P ⫽ 0.159; change in MAP:
12.1 ⫾ 2.5 mmHg, P ⫽ 0.121).

DISCUSSION

The major new finding of the present study is that
despite inducing vasoconstriction at baseline, systemic
NO synthase inhibition with L-NMMA does not alter
the increase in MSNA, heart rate, or TPR during
head-up tilt in healthy individuals. This observation
suggests that NO does not play an obligatory role in
the regulation of sympathetic outflow to muscle during
upright posture in humans.
Passive head-up tilt redistributes blood below the
heart. To maintain arterial blood pressure and cerebral
perfusion, a number of compensatory mechanisms are
activated. Importantly, heart rate and MSNA increase

Fig. 1. Representative tracings obtained from one subject. Integrated
muscle sympathetic nerve activity
(MSNA), arterial blood pressure (BP)
by Finapres, and beat-by-beat heart
rate [HR; in beats/min (bpm)] at supine
and 60° head-up tilt position during
control and NG-monomethyl-L-arginine (L-NMMA) infusion conditions are
shown.

AJP-Heart Circ Physiol • VOL
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Fig. 2. Average values of MSNA expressed as burst rate and normalized total activity at supine and 60° head-up tilt positions during
control and L-NMMA infusion conditions; n ⫽ 6 subjects. *P ⬍ 0.05
compared with the supine position; #P ⬍ 0.05 compared with control
conditions.

rapidly secondary to cardiopulmonary and arterial
baroreceptor unloading during head-up tilt. Besides
these baroreflex control mechanisms, muscle afferent
(29) and vestibular (9) systems may also be involved to
regulate sympathetic outflow during head-up tilt. In
addition, some local reflexes, such as myogenic (15) and
venoarteriolar reflexes (6), may be provoked during
head-up tilt. However, relative to autonomic neural
control mechanisms, the contribution of these local
reflexes may only moderately contribute to the systemic vascular responses during head-up tilt. Taken
together, the increase in MSNA during head-up tilt is
regulated by a multi-input control system including
central mechanisms. The significant and appropriate
(relative to the control condition) increase in MSNA,
TPR, and heart rate evoked by head-up tilt after systemic L-NMMA administration suggests that NO-related mechanisms do not play an obligatory role in
these responses.
Prior studies showed that inhibition of NO synthase
does not alter baroreflex control of sympathetic nerve
AJP-Heart Circ Physiol • VOL

activity and heart rate in animals (13, 17, 21, 22, 26)
and humans (30). In contrast, the increase in MSNA
evoked by LBNP at ⫺20 mmHg was attenuated after
systemic infusion of NG-nitro-L-arginine methyl ester
(L-NAME) (4). But when greater orthostatic stress
(⫺30 and ⫺40 mmHg LBNP) was applied, the MSNA
response was similar to the control condition during
systemic NO synthase inhibition (4, 30). However, low
levels of LBNP may be only a modest baroreceptor
unloading stimulus, and the magnitude of orthostatic
stimulus with 60° head-up tilt in the present study
should be greater than that with these levels of LBNP
(16). Moreover, we (5) have recently reported that after
L-NMMA administration, similar changes in blood
pressure and R-R variability during head-up tilt were
observed compared with those without L-NMMA.
Therefore, the present results confirm and extend previous observations by demonstrating that a systemically effective dose of L-NMMA (prime loading ⫹
steady-state infusion) leads to vasoconstriction, hypertension, and appropriate baroreflex inhibition of
MSNA, but hemodynamic reflex responses are preserved during a clinically relevant orthostatic stress
(e.g., 60° head-up tilt).
We observed that the increase in heart rate during
upright tilt was similar between control and L-NMMA
trials. This is in contrast to previously reported observations that administration of L-NMMA abolished the
heart rate response to LBNP, suggesting that baroreflex control of heart rate may be impaired by NO
synthase inhibition in humans (30). It is likely that
discrepancies between these two studies are related to
differences in the magnitude of baroreflex unloading
between the ⫺30 mmHg LBNP used by Spieker et al.
(30) and the 60° head-up tilt used in the present investigation.
In the present study, MSNA, expressed either as
burst rate or total activity, decreased significantly in
the supine position after L-NMMA, which is consistent
with the finding of others who administered higher
doses of L-NMMA (12, 18). In contrast, small doses of
L-NMMA increase basal MSNA (18, 23), thus raising
the possibility that the effects of L-NMMA on basal
MSNA may be dose dependent, as suggested by Lepori
et al. (18). We do not know the mechanism by which
small doses of L-NMMA increase MSNA except that
some degree of central sympathoexcitation may occur,
whereas this response is not observed if blood pressure
is elevated due to a dose of L-NMMA sufficient to evoke
a baroreflex-mediated inhibition of sympathetic activity. Thus the effect of L-NMMA on the control of MSNA
is likely a result of a combination of central versus
peripheral effects of NO synthase inhibition. Nevertheless, the present data show that, at the doses administered, systemic inhibition of NO synthase does not
alter regulation of MSNA during head-up tilt, which
suggests that baroreflexes are not altered.
Despite significant increases in blood pressure with
L-NMMA administration, supine heart rate did not
change when NO synthase was inhibited. This observation is consistent with some (30) but not all studies

285 • NOVEMBER 2003 •

www.ajpheart.org

Downloaded from journals.physiology.org/journal/ajpheart at Smith Col Libs (144.121.036.209) on May 10, 2022.

MSNA REGULATION WITH L-NMMA DURING HEAD-UP TILT

(12, 18, 28). Moreover, some observations (30, 31) show
that cardiac output decreases after L-NMMA infusion,
which is in contrast to the present findings. These
differences in cardiac output responses may be related
to the aforementioned differences in findings with respect to the effects of systemic inhibition of NO synthase on heart rate.
Study limitations. Supine blood pressure increases
and MSNA decreases after infusion of L-NMMA. To
control for these different blood pressure baselines,
some studies used vasoactive agents (e.g., nitroprusside) to prevent the rise in blood pressure via NO
synthase inhibition. However, the effects of nitroprusside on central venous pressure should not be neglected. Moreover, nitroprusside may have direct effects on the central nervous system (14). Infusion of
phenylephrine can elevate mean arterial blood pressure to the level observed after L-NMMA infusion, but
systemic phenylephrine administration also increases
central venous pressure, whereas central venous pressure was not changed after L-NMMA infusion (30).
Therefore, it is difficult to obtain similar hemodynamic
responses between control and L-NMMA conditions
with these vasoactive agents.
Although baroreflex control of MSNA can be expressed as a sigmoidal shape with both threshold and
saturation, within a narrow range of changes in blood
pressure around an operating point, these responses
are linear. Therefore, comparison of changes in MSNA
during tilt from different baselines in the supine position before and after L-NMMA should not have significant effects on the interpretation of the present data.
The influence of NO synthase inhibition on venous
tone is controversial. Several studies (11, 33) have
suggested that NO does not contribute to resting venous tone, whereas Blackman et al. (2) showed that
inhibition of NO synthase might alter the vascular
tone of small forearm veins and venules. Therefore, we
cannot exclude the possibility that infusion of L-NMMA
might alter vascular tone of small veins and venules.
However, Spieker et al. (30) showed that changes in
central venous pressure induced by ⫺30 mmHg LBNP
were similar regardless of the presence or absence of
L-NMMA. Moreover, the change in stroke volume by
head-up tilt with L-NMMA was similar with that in
control condition in the present study. Thus it is likely
that changes in central venous pressure in the present
study was similar during the orthostatic challenge
with or without L-NMMAN infusion. Therefore, a potential influence of NO synthase inhibition on venous
tone would be unlikely to cause significant differences
in the magnitude of baroreceptor unloading during
head-up tilt. Nevertheless, we cannot exclude the possibility that NO synthesis inhibition might have a
minor influence on the magnitude of fluid shift during
upright tilt, which in turn could induce some minor
and nonsignificant changes in hemodynamic parameters, such as cardiac output.
In conclusion, during inhibition of NO synthase via
systemic infusion of L-NMMA, MSNA, TPR, and heart
rate increased appropriately during head-up tilt. These
AJP-Heart Circ Physiol • VOL
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observations suggest that NO does not have an obligatory role in the regulation of sympathetic outflow to
muscle during head-up tilt in humans.
The authors express appreciation to the subjects for willing participation in this project.
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